The PROACT II Study : A Randomized Controlled Trial Intra-arterial Prourokinase for Acute Ischemic Stroke :

[1]  P. Sandercock,et al.  MEGA TRIALS VERSUS SMALL TRIALS IN STROKE , 2001 .

[2]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[3]  K Marcdante,et al.  Medical College of Wisconsin. , 2000, Academic medicine : journal of the Association of American Medical Colleges.

[4]  K. Muir,et al.  Neuroprotection for acute stroke: making clinical trials work. , 1999, Stroke.

[5]  S. Ohta,et al.  Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. , 1998, Stroke.

[6]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[7]  GerhardSchroth,et al.  Local Intra-Arterial Thrombolysis in Acute Ischemic Stroke , 1998 .

[8]  G. Schroth,et al.  Local intra-arterial thrombolysis in acute ischemic stroke. , 1998, Stroke.

[9]  V. Gurewich,et al.  Intra-arterial pro-urokinase in ischemic stroke. , 1998, Stroke.

[10]  R. E. Donnelly,et al.  Rapid identification and treatment of acute stroke , 1998 .

[11]  R. Higashida,et al.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. , 1998, Stroke.

[12]  L Bozzao,et al.  Acute stroke: usefulness of early CT findings before thrombolytic therapy. , 1997, Radiology.

[13]  Tissue-plasminogen activator for acute ischaemic stroke , 1997, The Lancet.

[14]  M Fisher,et al.  Evolving stroke and the ischemic penumbra , 1996, Neurology.

[15]  G. Hankey,et al.  Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. , 1996, JAMA.

[16]  T Moulin,et al.  Early CT signs in acute middle cerebral artery infarction , 1996, Neurology.

[17]  J. Broderick,et al.  Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. , 1996, AJNR. American journal of neuroradiology.

[18]  J. Baron,et al.  Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. , 1995, Stroke.

[19]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[20]  M Fisher,et al.  New magnetic resonance techniques for acute ischemic stroke. , 1995, JAMA.

[21]  J. Wójcik,et al.  Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase. , 1995, Journal of the American College of Cardiology.

[22]  J. Gardenier.  Letter , 1995 .

[23]  M. Pessin,et al.  CHAPTER 34 – Thrombolytic Treatment in Acute Stroke: Review and Update of Selective Topics , 1995 .

[24]  R. Higashida,et al.  The Case for a Phase III Trial of Cerebral Intraarterial Fibrinolysis , 1994 .

[25]  R. D. Ferguson,et al.  Cerebral intraarterial fibrinolysis at the crossroads: is a phase III trial advisable at this time? , 1994, AJNR. American journal of neuroradiology.

[26]  D. Toni,et al.  Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion , 1994, Journal of the Neurological Sciences.

[27]  M. Pessin,et al.  Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. , 1993, AJNR. American journal of neuroradiology.

[28]  W. Hacke,et al.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke , 1992, Annals of neurology.

[29]  N. Taub,et al.  Assessment of Scales of Disability and Handicap for Stroke Patients , 1991, Stroke.

[30]  A. Furlan,et al.  Natural History of Atherothromboembolic Occlusion of Cerebral Arteries: Carotid Versus Vertebrobasilar Territories , 1991 .

[31]  P. Courtheoux,et al.  Local intraarterial fibrinolysis in the carotid territory. , 1989, AJNR. American journal of neuroradiology.

[32]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[33]  M. Fujishima,et al.  Hemorrhagic transformation in cerebral embolism. , 1989, Stroke.

[34]  J. Slattery,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1989, Stroke.

[35]  Gregory,et al.  Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. , 1988, Stroke.

[36]  A. Yamadori,et al.  Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. , 1988, Stroke.

[37]  W. Hacke,et al.  Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. , 1988, Stroke.

[38]  V. Gurewich,et al.  Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. , 1988, The Journal of clinical investigation.

[39]  J. Lodder,et al.  Cerebral hemorrhagic infarction at autopsy: cardiac embolic cause and the relationship to the cause of death. , 1986, Stroke.

[40]  V. Gurewich,et al.  Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect. , 1986, Blood.

[41]  C. Hornig,et al.  Hemorrhagic cerebral infarction--a prospective study. , 1986, Stroke.

[42]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[43]  T. Suyama,et al.  Primary structure of single-chain pro-urokinase. , 1985, The Journal of biological chemistry.

[44]  F. Lefevre.  The Cleveland Clinic Foundation. , 1968, Minnesota medicine.